| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 10.05. | These Analysts Lower Their Forecasts On Revance Therapeutics After Q1 Results | 13 | Benzinga.com | ||
| 09.05. | Revance Therapeutics, Inc. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 09.05. | Revance Reports First Quarter 2024 Financial Results, Provides Corporate Update | 391 | Business Wire | NASHVILLE, Tenn.--(BUSINESS WIRE)--Revance Therapeutics, Inc. (NASDAQ: RVNC), today reported financial results for the first quarter ended March 31, 2024 and provided a corporate update.
Financial... ► Artikel lesen | |
| 03.05. | Revance Therapeutics, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 19.03. | Revance Therapeutics CLO & GC Dwight Moxie sells shares worth $40,971 | 6 | Investing.com | ||
| 19.03. | Revance Therapeutics CFO sells over $47,000 in company stock | 8 | Investing.com | ||
| 19.03. | Revance Therapeutics president sells over $46k in company stock | 8 | Investing.com | ||
| 11.03. | Revance stock rises after CEO discloses share purchase | 9 | Seeking Alpha | ||
| 04.03. | Revance Therapeutics drops after $100 million stock offering prices | 10 | Reuters | ||
| 04.03. | Revance Therapeutics drops on $100 million stock offering plans | 4 | Reuters | ||
| 04.03. | Revance Therapeutics down 7%, prices $100M share offering | 3 | Seeking Alpha | ||
| 04.03. | Revance announces $100 million stock offering | 1 | Investing.com | ||
| 02.03. | Revance Therapeutics, Inc. (RVNC) Q4 2023 Earnings Call Transcript | 2 | Insider Monkey | ||
| 01.03. | Earnings call: Revance Therapeutics reports robust growth in 2023 | 4 | Investing.com | ||
| 29.02. | Revance Therapeutics Inc reports results for the quarter ended in December - Earnings Summary | 7 | Reuters | ||
| 29.02. | Revance Therapeutics, Inc. - S-8, Securities to be offered to employees in employee benefit plans | - | SEC Filings | ||
| 28.02. | Revance Therapeutics, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 28.02. | Revance Reports Fourth Quarter and Full Year 2023 Financial Results, Provides Corporate Update | 171 | Business Wire | NASHVILLE, Tenn.--(BUSINESS WIRE)--Revance Therapeutics, Inc. (NASDAQ: RVNC), today reported financial results for the fourth quarter and full year ended December 31, 2023 and provided a corporate... ► Artikel lesen | |
| 27.02. | Earnings Outlook For Revance Therapeutics | 3 | Benzinga.com | ||
| 06.02. | Revance Therapeutics, Inc. - 8-K, Current Report | 5 | SEC Filings |
Seite:
1 2 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| GAMESTOP | 5.137 |
| NEL | 3.211 |
| TUI | 3.087 |
| EVOTEC | 2.484 |
| NVIDIA | 2.144 |
| PLUG POWER | 1.552 |
| BAYER | 1.252 |
| BYD | 1.252 |
| BIONTECH | 1.170 |
| RHEINMETALL | 937 |
| VOLKSWAGEN | 915 |
| SUPER MICRO COMPUTER | 854 |
| DEUTSCHE LUFTHANSA | 837 |
| AMC ENTERTAINMENT | 712 |
| AIXTRON SE | 657 |
| DEUTSCHE TELEKOM | 651 |
| AMD | 593 |
| BASF | 542 |
| JINKOSOLAR | 536 |
| RWE | 525 |
| DEUTSCHE BANK | 496 |
| HEIDELBERGER DRUCK | 487 |
| TESLA | 479 |
| ALLIANZ | 473 |
| SIEMENS ENERGY | 466 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
